Spotlight
Topic
Brand Insights
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Document Leak: NICE Says No to MS
Article
Pharmaceutical Executive
Pharmaceutical ExecutivePharmaceutical Executive-09-01-2001
Volume 0
Issue 0
London-Schering and Biogen have both expressed anger over the leak of a National Institute of Clinical Excellence (NICE) document suggesting that doctors stop prescribing beta-interferon to new multiple sclerosis (MS) patients.
Articles in this issue
Profits and Promotion Under Attack
Church and State
Document Leak: NICE Says No to MS
Business Disposal: GSK Dumps Affymax
Criticism: Pharma Goes on the Attack
New Playing Fields
Inefficiencies: Cutting Through the Jungle
Legislation: EC Proposes Changes
Flexing Their Budgets: Big Pharma Spend Trends
Media Mix Town Meeting 2001: Much Ado About Media
Related Videos
Related Content
Fierce Females in the Life Science Space
March 29th 2024Podcast
In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
